What is myeloma?

A woman and man sitting closely together looking preoccupied

Myeloma is a blood cancer

Myeloma is the 2nd most common form of blood cancer, yet sadly most people have never heard of it. Myeloma is associated with the abnormal behaviour and uncontrolled growth of a type of white blood cell—the plasma cell. Plasma cells are made in the bone marrow—the spongy tissue found inside bones—and when they’re healthy, they are an important part of your body’s immune system because they help fight infection by producing antibodies that attack germs.

In myeloma, the plasma cells become cancerous (myeloma cells) and interfere with the production of healthy blood cells in the bone marrow. Instead of producing antibodies that fight infection and disease, myeloma cells produce abnormal proteins (called monoclonal protein, monoclonal immunoglobulin, or M-protein). These can cause serious complications and affect different parts of the body such as the bones and kidneys. Although myeloma is a blood cancer, sometimes myeloma cells collect and form a plasmacytoma (a tumour made of plasma cells).

The cause or causes of myeloma remain relatively unknown but there is increasing research that suggests possible associations between myeloma and a decline in immune function, genetic factors, and the environment.

The number of Canadians diagnosed with myeloma is steadily increasing year after year. While there is not yet a cure, people with myeloma are living longer and better lives thanks to recent breakthroughs in research and treatment.

An older East Asian couple looking worried as a younger woman shares news

What causes myeloma?

Learn more about the causes and precursors of myeloma, including Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smouldering Multiple Myeloma (SMM).

Beautiful mature woman with corgi dog pet in summer park

Myeloma vs. melanoma

Myeloma is often confused with melanoma. Myeloma, also sometimes called “multiple myeloma,” is a cancer of the plasma cells, a type of immune cell, in the bone marrow. Melanoma refers to a form of cancer that usually occurs in the skin, but can also occur in the eye and mucous membranes.

icon

Where “multiple myeloma” gets its name

Myeloma cells multiply in the bone marrow and interfere with the production of good, healthy red blood cells, white blood cells, and platelets. As a result, myeloma can affect several places in the body where bone marrow is normally active in adults (like the bones of the spine, skull, pelvis, and rib cage, as well as the long bones in arms and legs and areas around the shoulders and hips), which is why it’s often referred to as multiple myeloma.

Types of myeloma

Myeloma is not really just one disease. It’s a disease with several subtypes.

Instead of producing a variety of healthy antibodies (known as immunoglobulins) that can fight infection, myeloma cells (abnormal plasma cells) produce non-functional clones of one type of antibody commonly referred to as monoclonal antibodies, M-protein, monoclonal protein, paraprotein, myeloma protein, or M-spike.

Immunoglobulins are made up of 2 heavy chain proteins and 2 light chain proteins bound together.

There are:

  • five (5) types of heavy chains: G, A, M, D, or E
  • two (2) types of light chains: kappa (κ) or lambda (λ)

Structure of an antibody (immunoglobulin)

Structure of an antibody

 

The specific type of myeloma a person has is based
on the immunoglobulin (abbreviated as “Ig”) that is overproduced by the myeloma cells (eg, in IgG
lambda myeloma, myeloma cells overproduce an immunoglobulin made from 2 IgG heavy chains
bound to 2 lambda light chains.)

The 10 possible myeloma subtypes are:

  • IgG lambda
  • IgA lambda
  • IgM lambda
  • IgD lambda
  • IgE lambda
  • IgG kappa
  • IgA kappa
  • IgM kappa
  • IgD kappa
  • IgE kappa

About 60–65% of all cases of myeloma involve the overproduction of immunoglobulins made with “G” heavy
chains (IgG).

Some people (approximately 15–20%) with myeloma have light chain myeloma (also known as Bence-Jones myeloma) that secretes only light chains and no heavy chains in the urine.

An even smaller proportion of people (1–5%) with myeloma have non–secretory myeloma that secretes very little or no monoclonal protein.

IgM myeloma is very rare and typically occurs in Waldenstrom’s macroglobulinemia.

The relapsing-remitting nature of myeloma

Myeloma is a relapsing-remitting cancer. This means that it alternates between periods of heightened activity where symptoms and/or complications are active and need to be treated, and stable disease (remission) that’s often controlled by treatment, but not always.

A relapse is when myeloma returns or becomes active again after a period of remission or treatment.

It’s also important to know that it isn’t always necessary to treat myeloma right away. If the myeloma isn’t active or causing signs or symptoms, sometimes the chosen course of action is to wait and closely monitor the disease.

A Black woman doctor explaining to a mature white woman

Symptomatic or active myeloma

Symptomatic (active) myeloma requires treatment.

Symptoms associated with the overproduction of myeloma cells and monoclonal protein are commonly evaluated using the “CRAB” criteria:

list icon

HyperCalcemia – elevated calcium in the blood

list icon

Renal insufficiency – kidney damage

list icon

Anemia – low levels of hemoglobin in red blood cells (RBCs)

list icon

Lytic Bone lesions – pain in the bones and/or fractures

Other general symptoms include frequent or recurring infections and fatigue/weakness.

You may also hear the term “SLiM” (as defined by the International Myeloma Working Group) in relation to diagnosing myeloma. SLiM refers to a newer, more in-depth diagnostic set of criteria that better identifies people requiring active myeloma treatment even if they are not experiencing CRAB symptoms.

SLiM criteria include the following 3 Myeloma Defining Events (MDEs):

icon

Sixty percent (60%) or more myeloma cells in the bone marrow, and/or

icon

Light chains: Involved/uninvolved serum free light chain (sFLC) ratio of 100 or greater (the ratio of kappa-to-lambda or of lambda-to-kappa, depending on which light chain is present in larger quantities), and/or

icon

Magnetic resonance imaging (MRI): More than 1 bone lesion measuring at least 5 mm in size.

Multiple Myeloma Patient Handbook

For more information, download the Multiple Myeloma Patient Handbook

Designed to provide educational support to those living with myeloma, their caregivers, families, and friends, this handbook gives accurate, reliable, and clear information on myeloma. Among topics are in-depth discussions on what myeloma is, its causes and effects, treatment options in Canada, and how to manage your myeloma journey.

Coping with your diagnosis

A myeloma diagnosis comes with its own unique set of emotional hurdles and no one understands this better than another person living with myeloma.

“Do you recall the day you heard the words ‘You have myeloma?’ I vividly recall that day in 2002 when I was told that I had an incurable disease I had never heard of and that I had three to five years to live. I remember being overwhelmed by feelings of fear, panic, dread, terror but above all a feeling of aloneness.”

—Aldo Del Col
Co-Founder, Myeloma Canada

Black grandmother and granddaughter in loving embrace in the park

There is no “right” or “wrong” way to react

Whatever you’re feeling is natural and completely understandable. You’ve been given a lot to process and to come to terms with. The diagnosis affects everyone differently.

Hear from other people living with myeloma

A myeloma diagnosis can feel overwhelming, but you are not alone. The apprehensions you may be experiencing are a normal part of coming to terms with your diagnosis. Watch the videos below to hear from other patients and learn about available resources.

A group of people dressed in red at the top of a mountain at a Myeloma Canada March

You are not alone

Myeloma touches the lives of tens of thousands of Canadians. Whether you’re living with this disease or caring for someone who is, there are community-based support groups across Canada with people who understand the journey you’re on.

In addition to our network of local support groups, there are online (virtual) Facebook support groups and peer-to-peer support programs, so you never feel alone in your journey.

Multiple Myeloma Patient Handbook

For more information, download the Multiple Myeloma Patient Handbook

Designed to provide educational support to those living with myeloma, their caregivers, families, and friends, this handbook gives accurate, reliable, and clear information on myeloma. Among topics are in-depth discussions on what myeloma is, its causes and effects, treatment options in Canada, and how to manage your myeloma journey.